UCPVax, a therapeutic cancer vaccine composed of two distinct peptides from human telomerase reverse transcriptase (TERT), has shown safety and the ability to stimulate an immune reaction in non-small cell lung cancer trials (NCT02818426) [418]. Here, TERT is linked to non-small cell lung carcinoma.